cgp 12177 has been researched along with Adrenal Cancer in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cases, A | 1 |
| Bono, M | 1 |
| Gaya, J | 1 |
| Jimenez, W | 1 |
| Calls, J | 1 |
| Esforzado, N | 1 |
| Rivera, F | 1 |
| Revert, L | 1 |
1 other study available for cgp 12177 and Adrenal Cancer
| Article | Year |
|---|---|
Reversible decrease of surface beta 2-adrenoceptor number and response in lymphocytes of patients with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Aged; Case-Control Studies; Catecholami | 1995 |